¶ Roivant Sciences
.png)
Roivant Sciences is an American-Swiss pharmaceutical and biotechnology company based in New York City, with offices in Boston, Massachusetts and Basel, Switzerland. It was founded by Vivek Ramaswamy in 2014.[1]
¶ History
Ramaswamy incorporated the company on April 7, 2014 in Bermuda.[2][3]
On September 20, 2017, Roivant announced the launch of Datavant, "a new company focused on employing artificial intelligence to improve the clinical trial process."[4] Travis May and Sam Roosz are credited as co-founders.[5]
In April 2018, Roivant announced that it was joining forces with Arbutus Biopharma to launch Genevant Sciences, a jointly-owned venture focused on “the discovery, development, and commercialization of a broad range of RNA-based therapeutics” aiming for “5-10 product candidates into the clinic by 2020.”[6]
¶ COVID-19
On February 26, 2021, Roivant announced its acquisition of Silicon Therapeutics.[7]
¶ Organization
Roivant is a member company of the Biotechnology Innovation Organization (BIO).[8]
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Vivek Ramaswamy | Founder[2:1] | Strive Asset Management, Campus Venture Network |
| Jo Chen | General Counsel[9] | JHL Capital Group, Bain Capital, D. E. Shaw & Co., Weil, Gotshal & Manges |
| Alex Gasner | Executive Vice President | Bee |
| Matt Gline | Chief Executive Officer | Goldman Sachs, Fourthree, Barclays |
| Kelly Graff | Head of People | Interferometrics, Delta Analysis Group, Entegra Systems, Stevenson Search Partners, Occam Global, American Cancer Society (ACS) |
| Drew Krames | Chief Information Officer | Pivotal, VMWare, OneCloud |
| Rakhi Kumar | Chief Accounting Officer | The Medicines Company, Ernst & Young, NeuroPace |
| Amy Mahery | Chief Commercial Officer | EMD Serono |
| Matt Maisak | Chief Operating Officer | Axovant Sciences, Covant Therapeutics, Roche, Projects Abroad |
| Richard Pulik | Chief Financial Officer | Novartis, Merrill Lynch, UBS Investment Bank, Monitor Group, William Alanson White Institute |
| Srini Ramanathan | Chief Development Officer | Horizon Therapeutics, AbbVie, Gilead Sciences, Asian University for Women (AUW) |
| Mayukh Sukhatme | President and Chief Investment Officer | Narragansett Asset Management, Apothecary Capital, Sigma Capital, Sio Capital Management, Hutchin Hill Capital, Apple Tree Partners (ATP) |
| Frank Torti | Vant Chair | Telavant, Immunovant, New Enterprise Associates (NEA) |
| Eric Venker | President and Chief Operating Officer | NewYork-Presbyterian Hospital, Yale New Haven Hospital |
¶ Investors
Investors in Roivant include:[10][11][12]
- Dexcel Pharma
- Eventide
- Fidelity Investments
- Founders Fund
- NovaQuest Capital Management
- Palantir Technologies
- Patient Square Capital
- QVT Financial
- RTW Investments
- SoftBank Vision Fund[13]
- Sumitomo Pharma
- Suvretta Capital Management
- Viking Global Investors
¶ Portfolio
Companies in Roivant's portfolio include:[10:1][14][15]
- Affivant Sciences
- Arbutus Biopharma[16]
- Axovant Sciences
- Covant Therapeutics
- Datavant
- Dermavant Sciences
- Enzyvant[4:1]
- Gen-t Science
- Genevant Sciences
- Hemavant Sciences
- Immunovant
- Kinevant
- Lokavant
- Medallion
- Myovant Sciences[4:2]
- Priovant Therapeutics
- Proteovant Therapeutics
- Psivant Therapeutics
- Silicon Therapeutics[7:1]
- Telavant
- Urovant[4:3]
- VantAI
¶ Activities
Roivant has provided notable funding to:
¶ External links
Company Overview. Roivant. Retrieved May 27, 2024, from https://web.archive.org/web/20240527231807/https://www.roivant.com/about/company ↩︎
Lee, S. (2023, February 21). Roivant Sciences Announces Change to its Board of Directors. Roivant Sciences. https://web.archive.org/web/20230626001023/https://investor.roivant.com/news-releases/news-release-details/roivant-sciences-announces-change-its-board-directors ↩︎ ↩︎
Bermuda Registrar of Companies. (2017, January 10). Roivant Sciences Ltd. OpenCorporates. http://archive.today/2023.06.26-015348/https://opencorporates.com/companies/bm/48931 ↩︎
Davis, P., & Roosz, S. (2017, September 20). Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence. Roivant Sciences. https://web.archive.org/web/20210805175607/https://roivant.com/roivant-sciences-launches-datavant-to-improve-clinical-trials-with-artificial-intelligence.html ↩︎ ↩︎ ↩︎ ↩︎
Sam Roosz. Federation of American Scientists. Retrieved December 7, 2023, from https://web.archive.org/web/20231207011907/https://fas.org/expert/sam-roosz/ ↩︎
Tolmie, T., & Schull, D. (2018, April 11). Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases. Arbutus Biopharma. https://web.archive.org/web/20230207071630/https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-and-roivant-launch-genevant-sciences-industry-leading ↩︎
Landenberger, L. (2021, February 26). Roivant acquires Silicon Therapeutics for $450M in equity. BioWorld. https://web.archive.org/web/20240527233329/https://www.bioworld.com/articles/504117-roivant-acquires-silicon-therapeutics-for-450m-in-equity?v=preview ↩︎ ↩︎
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory ↩︎
Leadership. Roivant. Retrieved May 27, 2024, from https://web.archive.org/web/20240527231824/https://www.roivant.com/about/leadership ↩︎
Roivant Sciences - Financials. Crunchbase. Retrieved May 27, 2024, from https://www.crunchbase.com/organization/roivant-sciences/company_financials ↩︎ ↩︎
Private Equity Round - Roivant Sciences. Crunchbase. Retrieved May 27, 2024, from https://www.crunchbase.com/funding_round/roivant-sciences-private-equity--fb72be6a ↩︎
Company Overview. Roivant. Retrieved May 27, 2024, from http://archive.today/2024.05.27-231807/https://www.roivant.com/about/company ↩︎
Portfolio. SoftBank Vision Fund. Retrieved May 5, 2023, from https://web.archive.org/web/20230505171511/https://visionfund.com/portfolio ↩︎
Our Companies. Roivant. Retrieved May 27, 2024, from https://web.archive.org/web/20240527231832/https://www.roivant.com/companies ↩︎
Our Companies. Roivant. Retrieved August 15, 2022, from https://web.archive.org/web/20220815141030/https://www.roivant.com/companies ↩︎
Arbutus Biopharma - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved August 25, 2023, from https://www.crunchbase.com/organization/arbutus-biopharma/company_financials ↩︎
How We’re Funded. Alliance for Aging Research. Retrieved August 6, 2020, from https://web.archive.org/web/20200806210808/https://www.agingresearch.org/about-us/how-were-funded/ ↩︎
Annual Report 2018. (2018). Bipartisan Policy Center. https://web.archive.org/web/20220108073604/https://bipartisanpolicy.org/download/?file=/wp-content/uploads/2019/07/Annual-Report-2018.pdf ↩︎